Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific inhalation challenge

International Archives of Allergy and Immunology

Volumn 160, Issue 2, 2013, Pages 161-164

  Castano, Roberto ^a   Miedinger, David ^c   Maghni, Karim ^a   Ghezzo, Heberto ^a   Trudeau, Carole ^a   Castellanos, Lucero ^a   Wattiez, Mathieu ^d   Vandenplas, Olivier ^d   Malo, Jean Luc ^a,b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b Departments of Chest Medicine   (United Kingdom)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Airway remodeling; Metalloproteinase 9; Occupational asthma; Specific inhalation challenge

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ALLERGIC ASTHMA; ANALYZER; ARTICLE; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FLOUR; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL COUNT; OCCUPATIONAL ASTHMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SPUTUM ANALYSIS; SPUTUM LEVEL;

EID: 84866694232     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000339737     Document Type: Article

References (13)

1. Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA: Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 2005; 5: 257-263
2. Boulay ME, Prince P, Deschesnes F, Chakir J, Boulet LP: Metalloproteinase-9 in induced sputum correlates with the severity of the late allergen-induced asthmatic response. Respiration 2004; 71: 216-224
3. Cataldo DD, Bettiol J, Noel A, Bartsch P, Foidart JM, Louis R: Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002; 122: 1553-1559
4. Kelly EA, Busse WW, Jarjour NN: Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000; 162: 1157-1161
5. Vandenplas O, Malo JL: Inhalation challenges with agents causing occupational asthma. Eur Respir J 1997; 10: 2612-2629
6. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE: Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317
7. Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ: Matrix metalloproteinase-
8. expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002; 122: 1543-1552
9. Gueders MM, Foidart JM, Noel A, Cataldo DD: Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases. Eur J Pharmacol 2006; 533: 133-144
10. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamauchi K, Nagura H, Shirato K: Eosinophils as a source of matrix metalloproteinase-
11. in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16: 212-219
12. Bergeron C, Tulic MK, Hamid Q: Tools used to measure airway remodelling in research. Eur Respir J 2007; 29: 596-604
13. Larsson K: Monitoring airway remodeling in asthma. Clin Respir J 2010; 4(suppl 1):35-40.